These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Polymorphisms in platelet glycoproteins Ia and IIIa are associated with arterial thrombosis and carotid atherosclerosis in type 2 diabetes. Pellitero S; Reverter JL; Tàssies D; Pizarro E; Monteagudo J; Salinas I; Aguilera E; Sanmartí A; Reverter JC Thromb Haemost; 2010 Mar; 103(3):630-7. PubMed ID: 20076847 [TBL] [Abstract][Full Text] [Related]
5. Antiplatelet therapy in type 2 diabetes mellitus. Angiolillo DJ Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):124-31. PubMed ID: 17940430 [TBL] [Abstract][Full Text] [Related]
6. Atherosclerosis and diabetes mellitus. Zdanov VS; Vihert AM Bull World Health Organ; 1976; 53(5-6):547-53. PubMed ID: 1087194 [TBL] [Abstract][Full Text] [Related]
7. [From atherosclerosis to atherothrombosis : from a silent chronic pathology to an acute critical event]. Scheen AJ Rev Med Liege; 2018 May; 73(5-6):224-228. PubMed ID: 29926559 [TBL] [Abstract][Full Text] [Related]
8. Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Cavender MA; Steg PG; Smith SC; Eagle K; Ohman EM; Goto S; Kuder J; Im K; Wilson PW; Bhatt DL; Circulation; 2015 Sep; 132(10):923-31. PubMed ID: 26152709 [TBL] [Abstract][Full Text] [Related]
9. The pathway of neutrophil extracellular traps towards atherosclerosis and thrombosis. Moschonas IC; Tselepis AD Atherosclerosis; 2019 Sep; 288():9-16. PubMed ID: 31280097 [TBL] [Abstract][Full Text] [Related]
10. Hemostatic and metabolic abnormalities in diabetes mellitus. The search for a link. Piemontino U; Ceriello A; Di Minno G Haematologica; 1994; 79(4):387-92. PubMed ID: 7806096 [TBL] [Abstract][Full Text] [Related]
11. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. Beckman JA; Creager MA; Libby P JAMA; 2002 May; 287(19):2570-81. PubMed ID: 12020339 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus. Otsuki M; Goya K; Kasayama S Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106 [TBL] [Abstract][Full Text] [Related]
13. Early and Late Stent Thrombosis in Patients with Versus Without Diabetes Mellitus Following Percutaneous Coronary Intervention with Drug-Eluting Stents: A Systematic Review and Meta-Analysis. Yuan J; Xu GM Am J Cardiovasc Drugs; 2018 Dec; 18(6):483-492. PubMed ID: 30132141 [TBL] [Abstract][Full Text] [Related]
14. Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus. Soma P; Pretorius E Cardiovasc Diabetol; 2015 Jul; 14():96. PubMed ID: 26228646 [TBL] [Abstract][Full Text] [Related]
15. [Diabetes Mellitus, a prothrombotic disease]. Picard F; Adjedj J; Varenne O Ann Cardiol Angeiol (Paris); 2017 Dec; 66(6):385-392. PubMed ID: 29106832 [TBL] [Abstract][Full Text] [Related]
16. Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndrome. Venkatapuram S; Shannon RP Am J Ther; 2006; 13(1):64-71. PubMed ID: 16428924 [TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease. Fetterman JL; Holbrook M; Westbrook DG; Brown JA; Feeley KP; Bretón-Romero R; Linder EA; Berk BD; Weisbrod RM; Widlansky ME; Gokce N; Ballinger SW; Hamburg NM Cardiovasc Diabetol; 2016 Mar; 15():53. PubMed ID: 27036979 [TBL] [Abstract][Full Text] [Related]
18. The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis. Berezin AE; Kremzer AA; Berezina TA; Martovitskaya YV Acta Clin Belg; 2016 Feb; 71(1):38-45. PubMed ID: 27075791 [TBL] [Abstract][Full Text] [Related]
19. Endothelial Dysfunction in Type 2 Diabetes Mellitus. Dhananjayan R; Koundinya KS; Malati T; Kutala VK Indian J Clin Biochem; 2016 Oct; 31(4):372-9. PubMed ID: 27605734 [TBL] [Abstract][Full Text] [Related]
20. The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes--including reducing the risk of age and atherosclerosis. Hellstrom HR Med Hypotheses; 2007; 68(2):415-33. PubMed ID: 16828234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]